Venus Remedies trades higher on the bourses

24 Dec 2013 Evaluate

Venus Remedies is currently trading at Rs. 255.00, up by 13.75 points or 5.70% from its previous closing of Rs. 241.25 on the BSE.

The scrip opened at Rs. 241.90 and has touched a high and low of Rs. 258.40 and Rs. 241.90 respectively. So far 39791 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 358.05 on 15-May-2013 and a 52 week low of Rs. 140.00 on 02-Aug-2013.

Last one week high and low of the scrip stood at Rs. 258.40 and Rs. 222.20 respectively. The current market cap of the company is Rs. 288.57 crore.

The promoters holding in the company stood at 43.99% while Institutions and Non-Institutions held 8.58% and 47.43% respectively.

Venus Remedies has received innovative 100 award for its novel research product ‘ELORES’, a drug designed to fight superbugs to which other antibiotics failed to respond to, at an award function organized by ‘Inc. India’, business magazine in Delhi.

This award is recognition for the company’s effort in the field of AMR. ELORES is a new product and in a very short span of time, it has done exceptionally good in the market.

Venus Remedies is a pharmaceutical manufacturing company. The company provides formulations in area of antibiotics and oncological therapeutics. The company has two manufacturing facilities located in India and Germany. It manufactures Oncological and Cefelosporine Injectable products.

 

Venus Remedies Share Price

745.20 -7.70 (-1.02%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×